Theravance Biopharma
TBPH
TBPH
107 hedge funds and large institutions have $946M invested in Theravance Biopharma in 2020 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 33 increasing their positions, 32 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
9% less funds holding
Funds holding: 118 → 107 (-11)
42% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 26
Holders
107
Holding in Top 10
1
Calls
$69K
Puts
$1K
Top Buyers
| 1 | +$14.7M | |
| 2 | +$13.1M | |
| 3 | +$11M | |
| 4 |
Morgan Stanley
New York
|
+$8.31M |
| 5 |
BlackRock
New York
|
+$3.05M |
Top Sellers
| 1 | -$10.3M | |
| 2 | -$8.14M | |
| 3 | -$6.26M | |
| 4 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
-$2.59M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$2.2M |